Home » Automotive & Transportation » United States Parenteral Nutrition Market

United States Parenteral Nutrition Market By Nutrient Type (Single Dose Amino Acid Solution, Parenteral Lipid Emulsion, Carbohydrates, Trace Elements, Vitamins & Minerals) By Country – Growth, Future Prospects & Competitive Analysis, 2022 – 2030

Summary
Table Of Content

United States Parenteral Nutrition Market Overview

The United States Parenteral Nutrition market is witnessing substantial growth, with significant market values and a steady growth rate. In 2022, the market was valued at USD 1,908.05 million, indicating a robust presence in the healthcare sector. The market is projected to grow significantly, with an estimated USD 3,266.23 million by 2030. This growth trajectory reflects a Compound Annual Growth Rate (CAGR) of 6.66% from 2023 to 2030. Factors like the rising prevalence of chronic diseases, technological advancements in parenteral nutrition, and an increasing preference for home-based parenteral nutrition alongside a growing elderly population drive such growth. The market is thus positioned for substantial expansion in the coming years.

Parenteral nutrition, also known as total parenteral nutrition (TPN), is a medical method for delivering nutrients directly into the bloodstream, bypassing the gastrointestinal tract. This approach is essential for individuals unable to digest or absorb nutrients conventionally, often due to certain gastrointestinal disorders, severe burns, or after major surgery. The nutrition mixture, tailored to individual needs, typically includes protein, carbohydrates, fats, vitamins, and minerals, administered via a central venous catheter in the arm, chest, or neck. While parenteral nutrition is a lifesaving intervention, it requires meticulous monitoring, including regular blood tests to adjust the nutrient formula and to manage potential complications like infections, liver issues, or nutrient imbalances. Despite its effectiveness, enteral nutrition (tube feeding) is generally preferred due to lower complication risks, making parenteral nutrition a specialized, closely supervised treatment.

Access crucial information at unmatched prices!

Request your free sample report today & start making informed decisions powered by Credence Research!

Download Free Sample

United States Parenteral Nutrition Market Trends and Drivers

The US Parenteral Nutrition market is experiencing significant growth due to various factors. Primarily, the increasing prevalence of chronic illnesses is a significant driver. Chronic diseases like cancer and gastrointestinal disorders are becoming more common, necessitating enhanced nutritional support, which parenteral nutrition provides. Additionally, there’s a growing trend towards home parenteral nutrition. This method presents a more convenient option for patients requiring long-term parenteral feeding, allowing them to receive necessary care in the comfort of their homes.

Further driving the market are technological advancements in parenteral nutrition products. Innovations such as barcode assistance and advanced formulations are increasing the demand for these products and stimulating market growth. Another significant factor is the aging population and the rising incidence of natality, both of which are high-impact drivers for the market. Additionally, the shift towards e-commerce sales has made purchasing parenteral nutrition products more convenient, further boosting the market. Finally, the ongoing development of new products and the entry of new players in the market are pivotal in sustaining industry growth as companies strive to improve their existing portfolios and introduce innovative drugs.

United States Parenteral Nutrition Market Restraints

The United States Parenteral Nutrition market faces several challenges hindering its growth. A major impediment is the high cost of parenteral nutrition products, which restricts their accessibility to a broader patient base. Additionally, the risk of infections and other complications associated with these products is a significant concern, leading healthcare providers to consider alternative nutritional support methods. Stringent government regulations, especially in emerging economies, also hinder market expansion. Furthermore, a general lack of awareness about parenteral nutrition in developed countries impedes the industry’s growth. Factors such as the high cost of products, risks of infections, regulatory challenges, and a lack of public awareness are critical restraints in the US Parenteral Nutrition market, presenting obstacles that need to be addressed by industry stakeholders and policymakers for the market’s sustainable development.

Competitive Analysis

The United States Parenteral Nutrition market is witnessing substantial growth and is characterized by the presence of several major market players. The key players profiled in the United States Parenteral Nutrition market analysis include,

Baxter
Otsuka Pharmaceutical Factory, Inc.
B. Braun Melsungen AG
Fresenius SE & Co. KGaA
Grifols S.A
Pfizer, Inc.
Actavis, Inc.
Aculife (Nirlife)
Sichuan Kelun Pharmaceutical Co. Ltd.
Hospira, Inc.
Vifor Pharma

These companies are focusing on implementing strategies such as product innovations, mergers, acquisitions, joint ventures, alliances, and partnerships to improve their market position.

Regional Insights

North America, and particularly the United States, dominates the enteral and parenteral medical nutrition market. In 2022, the market value in North America was US$ 7,613.87 million, and it is projected to reach US$ 11,030.78 million by 2028, with an expected CAGR of 6.5% during the forecast period. This growth is attributed to factors such as the increasing prevalence of chronic diseases, strategic developments by market players, and a rising preference for enteral and parenteral nutrition. Additionally, growing awareness about the benefits of medical nutrition, including tube feeding for chronic health conditions, and government initiatives to raise public awareness are contributing to market growth.

Interesting Facts about the United States Parenteral Nutrition Market

The Parenteral Nutrition market in North America is experiencing substantial growth and is poised for continued expansion in the coming years. Some key facts and figures underscore this trend:

The U.S. leads the North American enteral and parenteral medical nutrition market with significant growth projections.
Market value exceeded $7.6 billion in 2022 and is expected to reach around $11 billion by 2028.
The high prevalence of chronic diseases like cancer and gastrointestinal disorders drives the market.
Technological advancements are key in developing safer and more efficient parenteral nutrition solutions.
Home parenteral nutrition is gaining popularity for its convenience and patient comfort.
Awareness initiatives and government campaigns are essential in promoting understanding and use of parenteral nutrition.
FDA approvals, like Fresenius Kabi’s SMOFlipid, are pivotal for introducing new nutrition solutions.
E-commerce has simplified access to parenteral nutrition products, influencing market dynamics.
Challenges include high costs, infection risks, and stringent regulations, particularly in emerging markets.

Notable developments within the industry include:

July 2021: Micrel Medical and Baxter Healthcare signed an agreement to distribute the Micrel Mini RythmicPN+ infusion pump in Australia and New Zealand, indicating innovation in parenteral nutrition products.
March 2021: Medical Nutrition International Industry data revealed that up to 50% of hospitalized COVID-19 patients in Belgium were malnourished, increasing the demand for parenteral nutrition.
2021: According to Medicare data, approximately 34,000 U.S. patients receive parenteral nutrition annually for critical ailments.
September 2022: The American Society for Parenteral and Enteral Nutrition conducted its annual Malnutrition Awareness Week.
March 2022: Fresenius Kabi received FDA approval for SMOFlipid, a pediatric parenteral nutrition product.
September 2022: Otsuka Pharmaceutical Co., Ltd. gained approval for ENEFLUID Injection, a comprehensive parenteral nutrition solution.
May 2022: Fresenius Kabi acquired Ivenix, Inc., enhancing its infusion therapy offerings in the U.S.

Shape Your Report to Specific Countries or Regions & Enjoy 30% Off!

Customize Now

Market Segmentations

By Nutrient Type

Single Dose Amino Acid Solution
Parenteral Lipid Emulsion
Carbohydrates
Trace Elements,
Vitamins & Minerals

By Country

Table of Content

Chapter No. 1 : Introduction. 35

1.1– Report Description. 35

1.1.1– Purpose of the Report 35

1.1.2– USP & Key Offerings. 35

1.2– Key Benefits for Stakeholders. 35

1.3– Target Audience. 36

1.4– Report Scope. 37

Chapter No. 2 : Executive Summary. 39

2.1– Parenteral Nutrition Market Snapshot 39

2.2– U.S. Parenteral Nutrition Market, 2017 – 2030 (USD Million) 40

Chapter No. 3 : Impact Analysis of COVID 19 & Russia-Ukraine War on Parenteral Nutrition Market 41

3.1– Impact Assessment of COVID-19 Pandemic, By Region. 41

3.1.1– Supply Chain Disruptions: 41

3.1.2– Economic Challenges: 41

3.1.3– Healthcare System Strain: 41

3.1.4– Focus on Critical Care: 41

3.1.5– Research and Development Challenges: 41

3.1.6– Regulatory Changes: 42

3.1.7– Patient Access and Adherence: 42

Chapter No. 4 : Parenteral Nutrition Market – Industry Analysis. 43

4.1– Introduction. 43

4.2– Market Drivers. 44

4.2.1– Presence of a large pool of malnourished children. 44

4.2.2– Growing adoption of parenteral nutrition by healthcare settings for nutrient administration. 44

4.2.3– Rising incidence of chronic diseases. 45

4.2.4– Increasing geriatric population. 45

4.3– Market Restraints. 47

4.3.1– Poor Monitoring. 47

4.3.2– Cost Constraints Coupled with Stringent Regulatory Requirements. 47

4.3.3– Lack of awareness among healthcare providers. 48

4.4– Market Opportunities. 49

4.4.1– Strong growth prospects in Asia Pacific. 49

4.4.2– Focus on Personalized Nutrition & Research in Disease-Specific Formulations. 50

4.4.3– Advancements in Nutrient Delivery Systems. 51

4.5– Porter’s Five Forces Analysis. 52

4.6– Value Chain Analysis. 53

4.7– Buying Criteria. 54

Chapter No. 5 : Analysis Competitive Landscape. 56

5.1– Company Market Share Analysis – 2022. 56

5.1.1– U.S. Parenteral Nutrition Market: Company Market Share, by Revenue2022. 56

5.1.2– U.S. Parenteral Nutrition Market: Top 6 Company Market Share, by Revenue2022. 56

5.1.3– U.S. Parenteral Nutrition Market: Top 3 Company Market Share, by Revenue2022. 57

5.1– U.S. Parenteral Nutrition Market Company Revenue Market Share, 2022. 58

5.2– Competitive Benchmarking, 2022. 59

5.3– Key Players Product Matrix. 60

Chapter No. 6 : PESTEL & Adjacent Market Analysis. 64

6.1– PESTEL. 64

6.1.1– Political Factors. 64

6.1.2– Economic Factors. 64

6.1.3– Social Factors. 64

6.1.4– Technological Factors. 64

6.1.5– Environmental Factors. 65

6.1.6– Legal Factors. 65

6.2– Adjacent Market Analysis. 66

Chapter No. 7 : Parenteral Nutrition Market – By Age Group Segment Analysis. 68

7.1– Parenteral Nutrition Market Overview, by Age Group Segment 68

7.1.1– Parenteral Nutrition Market Revenue Share, By Age Group, 2022 & 2030. 71

7.1.2– Parenteral Nutrition Market Attractiveness Analysis, By Age Group. 72

7.1.3– Incremental Revenue Growth Opportunity, by Age Group, 2023 – 2030. 72

7.1.4– Parenteral Nutrition Market Revenue, By Age Group, 2017, 2022, 2026 & 2030. 73

7.2– Adult 74

7.3– Pediatrics. 75

Chapter No. 8 : Parenteral Nutrition Market – By Application Segment Analysis. 76

8.1– Parenteral Nutrition Market Overview, by Application Segment 76

8.1.1– Parenteral Nutrition Market Revenue Share, By Application, 2022 & 2030. 78

8.1.2– Parenteral Nutrition Market Attractiveness Analysis, By Application. 79

8.1.3– Incremental Revenue Growth Opportunity, by Application, 2023 – 2030. 79

8.1.4– Parenteral Nutrition Market Revenue, By Application, 2017, 2022, 2026 & 2030. 80

8.2– Alzheimer’s. 81

8.3– CKD.. 82

8.4– Nutrition Deficiency. 83

8.5– Cancer Care. 84

8.6– Diabetes. 85

8.7– Others. 86

Chapter No. 9 : Parenteral Nutrition Market – By Type Segment Analysis. 87

9.1– Parenteral Nutrition Market Overview, by Type Segment 87

9.1.1– Parenteral Nutrition Market Revenue Share, By Type, 2022 & 2030. 89

9.1.2– Parenteral Nutrition Market Attractiveness Analysis, By Type. 90

9.1.3– Incremental Revenue Growth Opportunity, by Type, 2023 – 2030. 90

9.1.4– Parenteral Nutrition Market Revenue, By Type, 2017, 2022, 2026 & 2030. 91

9.2– Carbohydrates. 92

9.3– Parenteral Lipid Emulsion. 93

9.4– Single Dose Amino Acid Solution. 94

9.5– Trace Elements. 95

9.6– Others. 96

Chapter No. 10 :. Parenteral Nutrition Market – By End-user Segment Analysis. 97

10.1–. Parenteral Nutrition Market Overview, by End-user Segment 97

10.1.1- Parenteral Nutrition Market Revenue Share, By End-user, 2022 & 2030. 98

10.1.2- Parenteral Nutrition Market Attractiveness Analysis, By End-user 99

10.1.3- Incremental Revenue Growth Opportunity, by End-user, 2023 – 2030. 99

10.1.4- Parenteral Nutrition Market Revenue, By End-user, 2017, 2022, 2026 & 2030. 100

10.2–. Hospitals. 101

10.3–. Clinics. 102

10.4–. Others. 103

Chapter No. 11 :. Parenteral Nutrition Market – By Distribution Channel Segment Analysis. 104

11.1–. Parenteral Nutrition Market Overview, by Distribution Channel Segment 104

11.1.1- Parenteral Nutrition Market Revenue Share, By Distribution Channel, 2022 & 2030. 105

11.1.2- Parenteral Nutrition Market Attractiveness Analysis, By Distribution Channel 106

11.1.3- Incremental Revenue Growth Opportunity, by Distribution Channel, 2023 – 2030. 106

11.1.4- Parenteral Nutrition Market Revenue, By Distribution Channel, 2017, 2022, 2026 & 2030. 107

11.2–. Retail Pharmacies. 108

11.3–. Online. 109

11.4–. Institutional Sales. 110

Chapter No. 12 :. Company Profiles. 111

12.1–. Baxter 111

12.1.1- Company Overview.. 111

12.1.2- Product Portfolio. 112

12.1.3- Financial Overview.. 112

12.2–. Allergan. 113

12.2.1- Company Overview.. 113

12.2.2- Product Portfolio. 114

12.2.3- Financial Overview.. 114

12.3–. B. Braun Melsungen AG.. 115

12.3.1- Company Overview.. 115

12.3.2- Product Portfolio. 116

12.3.3- Financial Overview.. 116

12.4–. Otsuka Pharmaceutical Factory, Inc. 117

12.4.1- Company Overview.. 117

12.4.2- Product Portfolio. 118

12.4.3- Financial Overview.. 118

12.5–. Grifols, S.A. 119

12.5.1- Company Overview.. 119

12.5.2- Product Portfolio. 120

12.5.3- Financial Overview.. 120

12.6–. Vifor Pharma. 121

12.6.1- Company Overview.. 121

12.6.2- Product Portfolio. 122

12.6.3- Financial Overview.. 122

12.7–. Fresenius Kabi AG.. 123

12.7.1- Company Overview.. 123

12.7.2- Product Portfolio. 123

12.7.3- Financial Overview.. 124

12.8–. Sichuan Kelun Pharmaceutical Co., Ltd. 125

12.8.1- Company Overview.. 125

12.8.2- Product Portfolio. 126

12.8.3- Financial Overview.. 126

12.9–. Pfizer Inc. (Hospira Inc.) 127

12.9.1- Company Overview.. 127

12.9.2- Product Portfolio. 128

12.9.3- Financial Overview.. 128

Chapter No. 13 :. Research Methodology. 129

13.1–. Research Methodology. 129

13.2–. Phase I – Secondary Research. 130

13.3–. Phase II – Data Modeling. 130

13.3.1- Company Share Analysis Model 131

13.3.2- Revenue Based Modeling. 131

13.4–. Phase III – Primary Research. 132

13.5–. Research Limitations. 133

13.5.1- Assumptions 133

List of Figures

FIG NO. 1-.. U.S. Parenteral Nutrition Market Revenue, 2017 – 2030 (USD Million) 40

FIG NO. 2-.. Porter’s Five Forces Analysis for U.S. Parenteral Nutrition Market 52

FIG NO. 3-.. Value Chain Analysis for U.S. Parenteral Nutrition Market 53

FIG NO. 4-.. Company Share Analysis, 2022. 56

FIG NO. 5-.. Company Share Analysis, 2022. 56

FIG NO. 6-.. Company Share Analysis, 2022. 57

FIG NO. 7-.. Parenteral Nutrition Market – Company Revenue Market Share, 2022. 58

FIG NO. 8-.. Competitive Benchmarking, 2022. 59

FIG NO. 9-.. Parenteral Nutrition Market Revenue Share, By Age Group, 2022 & 2030. 71

FIG NO. 10- Market Attractiveness Analysis, By Age Group. 72

FIG NO. 11- Incremental Revenue Growth Opportunity by Age Group. 72

FIG NO. 12- Parenteral Nutrition Market Revenue, By Age Group, 2017, 2022, 2026 & 2030. 73

FIG NO. 13- U.S. Parenteral Nutrition Market for Adult, Revenue (USD Million) 2017 – 2030. 74

FIG NO. 14- U.S. Parenteral Nutrition Market for Pediatrics, Revenue (USD Million) 2017 – 2030. 75

FIG NO. 15- Parenteral Nutrition Market Revenue Share, By Application, 2022 & 2030. 78

FIG NO. 16- Market Attractiveness Analysis, By Application. 79

FIG NO. 17- Incremental Revenue Growth Opportunity by Application. 79

FIG NO. 18- Parenteral Nutrition Market Revenue, By Application, 2017, 2022, 2026 & 2030. 80

FIG NO. 19- U.S. Parenteral Nutrition Market for Alzheimer’s, Revenue (USD Million) 2017 – 2030. 81

FIG NO. 20- U.S. Parenteral Nutrition Market for CKD, Revenue (USD Million) 2017 – 2030. 82

FIG NO. 21- U.S. Parenteral Nutrition Market for Nutrition Deficiency, Revenue (USD Million) 2017 – 2030. 83

FIG NO. 22- U.S. Parenteral Nutrition Market for Cancer Care, Revenue (USD Million) 2017 – 2030. 84

FIG NO. 23- U.S. Parenteral Nutrition Market for Diabetes, Revenue (USD Million) 2017 – 2030. 85

FIG NO. 24- U.S. Parenteral Nutrition Market for Others, Revenue (USD Million) 2017 – 2030. 86

FIG NO. 25- Parenteral Nutrition Market Revenue Share, By Type, 2022 & 2030. 89

FIG NO. 26- Market Attractiveness Analysis, By Type. 90

FIG NO. 27- Incremental Revenue Growth Opportunity by Type. 90

FIG NO. 28- Parenteral Nutrition Market Revenue, By Type, 2017, 2022, 2026 & 2030. 91

FIG NO. 29- U.S. Parenteral Nutrition Market for Carbohydrates, Revenue (USD Million) 2017 – 2030. 92

FIG NO. 30- U.S. Parenteral Nutrition Market for Parenteral Lipid Emulsion, Revenue (USD Million) 2017 – 2030. 93

FIG NO. 31- U.S. Parenteral Nutrition Market for Single Dose Amino Acid Solution, Revenue (USD Million) 2017 – 2030. 94

FIG NO. 32- U.S. Parenteral Nutrition Market for Trace Elements, Revenue (USD Million) 2017 – 2030. 95

FIG NO. 33- U.S. Parenteral Nutrition Market for Others, Revenue (USD Million) 2017 – 2030. 96

FIG NO. 34- Parenteral Nutrition Market Revenue Share, By End-user, 2022 & 2030. 98

FIG NO. 35- Market Attractiveness Analysis, By End-user 99

FIG NO. 36- Incremental Revenue Growth Opportunity by End-user 99

FIG NO. 37- Parenteral Nutrition Market Revenue, By End-user, 2017, 2022, 2026 & 2030. 100

FIG NO. 38- U.S. Parenteral Nutrition Market for Hospitals, Revenue (USD Million) 2017 – 2030. 101

FIG NO. 39- U.S. Parenteral Nutrition Market for Clinics , Revenue (USD Million) 2017 – 2030. 102

FIG NO. 40- U.S. Parenteral Nutrition Market for Others, Revenue (USD Million) 2017 – 2030. 103

FIG NO. 41- Parenteral Nutrition Market Revenue Share, By Distribution Channel, 2022 & 2030. 105

FIG NO. 42- Market Attractiveness Analysis, By Distribution Channel 106

FIG NO. 43- Incremental Revenue Growth Opportunity by Distribution Channel 106

FIG NO. 44- Parenteral Nutrition Market Revenue, By Distribution Channel, 2017, 2022, 2026 & 2030. 107

FIG NO. 45- U.S. Parenteral Nutrition Market for Retail Pharmacies, Revenue (USD Million) 2017 – 2030. 108

FIG NO. 46- U.S. Parenteral Nutrition Market for Online, Revenue (USD Million) 2017 – 2030. 109

FIG NO. 47- U.S. Parenteral Nutrition Market for Institutional Sales, Revenue (USD Million) 2017 – 2030. 110

FIG NO. 48- Research Methodology – Detailed View.. 129

FIG NO. 49- Research Methodology. 130

List of Tables

TABLE NO. 1. :….. U.S. Parenteral Nutrition Market: Snapshot 21

TABLE NO. 2. :….. Drivers for the Parenteral Nutrition Market: Impact Analysis. 26

TABLE NO. 3. :….. Restraints for the Parenteral Nutrition Market: Impact Analysis. 29

What was the value of the U.S. Parenteral Nutrition market in 2022?

In 2022, the U.S. Parenteral Nutrition market was valued at approximately USD 1,908.05 million.

What is the projected market value of the U.S. Parenteral Nutrition market by 2030?

By 2030, the market is expected to reach around USD 3,266.23 million.

What is the expected Compound Annual Growth Rate (CAGR) of the U.S. Parenteral Nutrition market from 2023 to 2030?

The market is projected to grow at a CAGR of 6.66% during the period from 2023 to 2030.

What are the key drivers for the growth of the U.S. Parenteral Nutrition market?

Major drivers include the increasing prevalence of chronic illnesses, advancements in parenteral nutrition technology, growing demand for home parenteral nutrition, and a rising elderly population.

Purchase Options

Single User

$2699

Multi User

$3699

Custom Report

$5699

Request Free Sample

Have a question?

Don’t settle for less – trust Mitul to help you find the best solution.

Call: +91 6232 49 3207

EMAIL MITUL

Report delivery within 24 to 48 hours

– Other Info –

–What people say?-

I am very impressed with the information in this report. The author clearly did their research when they came up with this product and it has already given me a lot of ideas.

Jana Schmidt
CEDAR CX Technologies

– Connect with us –